Are you Dr. Guardino?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 63 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
875 Blake Wilbur Dr
Stanford, CA 94305Phone+1 650-736-0519Fax+1 650-734-3697
Summary
- Dr. Alice Guardino, MD is an oncologist in Stanford, California. She is currently licensed to practice medicine in California. She is .
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2000 - 2004
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1997 - 2000
Georgetown University School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 2000 - 2020
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 87 citationsTrastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: An Integrated Safety AnalysisVéronique Diéras, Nadia Harbeck, G. Thomas Budd, Joel K. Greenson, Alice Elizabeth Guardino
Journal of Clinical Oncology. 2014-09-01 - 285 citationsTrastuzumab-related cardiotoxicity: calling into question the concept of reversibility.Melinda L. Telli, Sharon A. Hunt, Robert W. Carlson, Alice E. Guardino
Journal of Clinical Oncology. 2007-08-10 - 150 citationsRelationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast CancerJosé Baselga, Gail Lewis Phillips, Sunil Verma, Jungsil Ro, Jens Huober
Clinical Cancer Research. 2016-02-26
Press Mentions
Recipients of AACR Research Funding & Fellowships 1993–2017September 8th, 2017
